Results 91 to 100 of about 116,347 (217)

Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma

open access: yesJournal of International Medical Research
Objective Follicular lymphoma (FL) is an indolent, lymphoproliferative disease of B-cell origin that has a heterogeneous disease course with varying outcomes. Certain patients may undergo autologous stem cell transplantation.
Anna Kenyeres   +4 more
doaj   +1 more source

Evaluation of the Repair of Bone Defect after Bone Marrow Stromal Cell Transplantation in Rat

open access: yesJournal of Fasa University of Medical Sciences, 2013
Background & Objective: Bone marrow stromal cells (BMSCs) are multipotent stem cells that can proliferate and differentiate into osteogenic cells . T his study aimed to investigate the effects of BMSC transplantation for the repair of bone defects in the
Roghayeh Rezaei   +6 more
doaj  

Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation

open access: yes, 2006
Renal insufficiency is a common complication early after hematopoietic stem cell transplantation ( HSCT). Renal function as measured by creatinine clearance (CrCl) was prospectively evaluated in 47 patients undergoing allogeneic (n = 22) or autologous (n
Sargin, D.   +3 more
core   +1 more source

Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient

open access: yesInternational Journal of Infectious Diseases, 2015
The duration of a protective level of yellow fever antibodies after autologous hematopoietic stem cell transplantation in a previously vaccinated person is unclear.
Kayoko Hayakawa   +10 more
doaj   +1 more source

Diffusion-weighted imaging for the follow-up of patients after matrix-associated autologous chondrocyte transplantation

open access: yes, 2010
To evaluate the use of diffusion-weighted imaging (DWI) for the assessment of cartilage maturation in patients after matrix-associated autologous chondrocyte transplantation (MACT)
Welsch, G   +7 more
core   +1 more source

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells : implications for adoptive immunotherapy after allogeneic stem cell transplantation

open access: yes, 2010
Background: Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood and has a poor prognosis. Here we assessed the capability of ex vivo expanded cytokine-induced killer cells to lyse both alveolar and embryonic rhabdomyosarcoma cell lines ...
H. Kreyenberg   +38 more
core   +1 more source

Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI

open access: yes, 2013
Cardiac cell therapy with mesenchymal stem cells (MSCs) represents a promising treatment approach for end-stage heart failure. However, little is known about the underlying mechanisms and the fate of the transplanted cells. The objective of the presented
Neef, Klaus   +11 more
core   +1 more source

Autologous osteochondral transplantation

open access: yesActa Orthopaedica et Traumatologica Turcica, 2020
The surface of diarthrodial joints is covered by hyaline cartilage whose regeneration capacity is extremely limited. Conventional surgical techniques enable repair of fullthickness articular cartilage defects only by fibrous cartilage having poor ...
Emin TAŞKIRAN, Çağrı ÖZÇELİK
doaj  

CO- TRANSPLANTATION OF BONE MARROW STROMAL CELLS WITH SCHWANN CELLS EVOKES MECHANICAL ALLODYNIA IN THE CONTUSION MODEL OF SPINAL CORD INJURY IN RATS [PDF]

open access: yes
Objective: Several studies have shown that, although transplantation of neural stem cells into the contusion model of spinal cord injury (SCI) promotes locomotor function and improves functional recovery, it induces a painful response, Allodynia ...
جغتایی, محمد تقی   +5 more
core  

Dendritic cell recovery after autologous stem cell transplantation

open access: yes, 2002
There is persistent immunosuppression not only in allogeneic but also in autologous stem cell transplantation because humoral and cellular immunity may take a year or more to return to normal, with increased risk of infectious complications.
Baccarani, M   +21 more
core   +1 more source

Home - About - Disclaimer - Privacy